Prohost Portfolio PLUS #6
Yes, it is a Miracle!
Intellia Therapeutics and Regeneron Pharmaceuticals
This miracle news from Intellia Therapeutics and Regeneron Pharmaceuticals came Saturday, a day when the Market is taking rest from the usual yo-yoing of good/bad reasons and no reasons.
This miracle of great news emanated from Intellia Therapeutics.
The first-ever clinical data from a trial that supports safety and efficacy of in vivo CRISPR genome editing in humans.
The interim readout in the ongoing Phase 1 trial . . .
This content is for paid subscribers.
Prohost Letters June 29, 2021